Sustainability & Climate

Inspira Technologies announces a landmark deal to acquire a liquid biopsy firm, securing a $15M investment at a $180M valuation to enter the cancer market.

Dash cam leader Nextbase is turning millions of drivers into data collectors with its new InSight platform, promising to reshape our cities and roads.

Fewer than 10% of hospitals achieve Magnet status. City of Hope just earned it twice. Discover what this rare honor means for patient safety and nursing.

With a fresh funding series, Clipto.AI is pioneering a privacy-first future where powerful AI processes your sensitive content directly on your device.

A new firm, Rapid Drone, enters the booming drone market not as a maker, but as a specialized service provider using secure, US-certified aircraft.

Following a period of mixed financials, Neogen appoints new leaders to drive innovation and growth in its critical global food safety division.

A new initiative is tackling the fear and distrust that costs patients their health and the system trillions. Is 'cognitive safety' healthcare's next frontier?

With a $257M war chest and a veteran team, BlossomHill will showcase its innovative pipeline for lung cancer and leukemia at the pivotal JPM conference.

With surging revenue for its cholesterol drugs and new guideline backing, Esperion outlines its strategy for profitability and pipeline expansion.

Post-merger, Kepler Fusion unveils its strategy for commercializing compact, aneutronic fusion reactors, betting on a distributed 'Power-as-a-Service' model.

A new partnership aims to accelerate driver safety tech in next-gen vehicles, merging AI monitoring with a fortress-like operating system.

Routeware appoints proven tech leaders Jeremy Collins and Ray Greer to drive its next growth phase, focusing on platform modernization and market leadership.

A new therapy claims to reverse cellular aging to cure disease, but its patient-funded trial model sparks a debate on equity and medical ethics.

China's ETF market had a record 2025, fueled by AI breakthroughs and state support. A look at the boom, the leaders, and the risks ahead.

LENZ Therapeutics partners with Lunatus to launch its breakthrough VIZZ™ presbyopia eye drops in the Middle East, targeting a vast, unmet medical need.

The new over-the-counter molecular test could deliver results in 30 minutes, aiming to revolutionize STI diagnostics and tap into a $1.5B market.

With promising 3-year vision data and a manufacturing breakthrough, Lineage is pioneering 'off-the-shelf' cell therapies for blindness, diabetes, and more.

A premium meal service enters the D.C. market not with ads, but with community aid and a rare, profitable business model that defies industry trends.

New 2025 U-Haul data reveals a sustained migration to southern states like Texas and Florida, while California and New York see a continued exodus.

A global RFA leader unveils a new identity, reflecting a strategic shift from pure engineering to a focus on the patient's quality of life.